EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 380 (2) , 403-412
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosisArchives of Medical Science, 2014
- EYA1 Phosphatase Function Is Essential to Drive Breast Cancer Cell Proliferation through Cyclin D1Cancer Research, 2013
- Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial–mesenchymal transition, and cancer stem cell propertiesOncogene, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Inhibition of Eyes Absent Homolog 4 expression induces malignant peripheral nerve sheath tumor necrosisOncogene, 2009
- Regulation of the innate immune response by threonine-phosphatase of Eyes absentNature, 2009
- Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation ProfilingPLOS ONE, 2008
- The transcription factor Eyes absent is a protein tyrosine phosphataseNature, 2003
- Eyes absent represents a class of protein tyrosine phosphatasesNature, 2003
- The Eye-Specification Proteins So and Eya Form a Complex and Regulate Multiple Steps in Drosophila Eye DevelopmentCell, 1997